Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,257Revenue $M2,133Net Margin (%)2.9Z-Score3.5
Enterprise Value $M3,047EPS $2.7Operating Margin %6.9F-Score4
P/E(ttm))53.6Cash Flow Per Share $6.5Pre-tax Margin (%)4.8Higher ROA y-yN
Price/Book1.510-y EBITDA Growth Rate %9.0Quick Ratio2.6Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %-1.3Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow16.0y-y EBITDA Growth Rate %-19.1ROA % (ttm)1.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)2.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.9ROI % (ttm)3.8Gross Margin Increase y-yN

Gurus Latest Trades with BIO

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIONWQ Managers 2014-06-30 Add0.11%$118.68 - $129.7
($122.14)
$ 112.58-8%Add 20.72%523,806
BIOJohn Burbank 2014-06-30 Sold Out -0.02%$118.68 - $129.7
($122.14)
$ 112.58-8%Sold Out0
BIONWQ Managers 2014-03-31 Add0.12%$121.07 - $133.73
($128.05)
$ 112.58-12%Add 30.77%433,899
BIOJohn Burbank 2014-03-31 Buy 0.02%$121.07 - $133.73
($128.05)
$ 112.58-12%New holding, 4652 sh.4,652
BIOJohn Rogers 2014-03-31 Reduce-0.12%$121.07 - $133.73
($128.05)
$ 112.58-12%Reduce -7.06%1,024,729
BIONWQ Managers 2013-12-31 Add0.34%$115.53 - $124.5
($121.87)
$ 112.58-8%Add 1376.49%331,811
BIOJohn Rogers 2013-09-30 Add0.15%$112.74 - $125.8
($118.02)
$ 112.58-5%Add 8.32%1,096,613
BIONWQ Managers 2013-09-30 Buy 0.03%$112.74 - $125.8
($118.02)
$ 112.58-5%New holding, 22473 sh.22,473
BIOPrivate Capital 2013-03-31 Reduce-0.05%$105.05 - $126
($117.3)
$ 112.58-4%Reduce -22.47%16,887
BIOJoel Greenblatt 2013-03-31 Sold Out -0.04%$105.05 - $126
($117.3)
$ 112.58-4%Sold Out0
BIOJoel Greenblatt 2012-12-31 Reduce-0.09%$100.02 - $109.55
($103.99)
$ 112.588%Reduce -65.94%6,350
BIOGeorge Soros 2012-09-30 Sold Out -0.02%$92.4 - $109.42
($101.33)
$ 112.5811%Sold Out0
BIOMario Gabelli 2012-06-30 Add0.07%$95.57 - $116
($103.12)
$ 112.589%Add 2335.14%90,100
BIOGeorge Soros 2012-06-30 Buy 0.02%$95.57 - $116
($103.12)
$ 112.589%New holding, 15000 sh.15,000
BIOJoel Greenblatt 2012-03-31 Add0.07%$96.64 - $105.67
($94.65)
$ 112.5819%Add 56.04%22,134
BIOJoel Greenblatt 2011-12-31 Buy 0.16%$88.92 - $102.55
($95.3)
$ 112.5818%New holding, 14185 sh.14,185
BIOGeorge Soros 2011-06-30 Sold Out $117.11 - $126.34
($121.89)
$ 112.58-8%Sold Out0
BIOGeorge Soros 2011-03-31 Buy 0.01%$103.85 - $119.58
($111.64)
$ 112.581%New holding, 3900 sh.3,900
BIOMario Gabelli 2011-03-31 Reduce$103.85 - $119.58
($111.64)
$ 112.581%Reduce -60.67%3,500
BIOPrivate Capital 2010-09-30 Reduce-0.09%$81.5 - $91.51
($87.09)
$ 112.5829%Reduce -24.95%43,332
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIO NWQ Managers 2014-06-30523,8061.810.63+20.72%
BIO Mario Gabelli 2014-06-3093,2000.320.06-1.48%
BIO Private Capital 2014-06-3016,0520.060.22-2.43%
BIO John Rogers 2014-06-30983,4523.411.4-4.03%
BIO Ken Fisher 2014-06-30294,7411.020.07-12.58%
BIO John Burbank 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BIO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about BIO :

    Quarterly/Annual Reports about BIO:

    News about BIO:

    Articles On GuruFocus.com
    Bio-Rad to Report Third-Quarter 2014 Financial Results Tuesday, November 4, 2014 Oct 15 2014 
    Bio-Rad Appoints John Goetz as Chief Operating Officer and Announces Other Executive Appointments Oct 15 2014 
    Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
    Guru Held Stocks Near Historical Low P/B Jul 22 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/B May 12 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 23 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 14 2014 

    More From Other Websites
    NYSE stocks posting largest volume increases Oct 29 2014
    Bio-Rad to Report Third-Quarter 2014 Financial Results Tuesday, November 4, 2014 Oct 08 2014
    BIO RAD LABORATORIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Oct 01 2014
    Bio-Rad Appoints John Goetz as Chief Operating Officer and Announces Other Executive Appointments Oct 01 2014
    BIO RAD LABORATORIES INC Files SEC form 8-K, Change in Directors or Principal Officers Aug 29 2014
    BIO RAD LABORATORIES INC Financials Aug 13 2014
    BIO RAD LABORATORIES INC Files SEC form 10-Q, Quarterly Report Aug 06 2014
    BIO RAD LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 05 2014
    Bio-Rad Reports Second-Quarter 2014 Financial Results Aug 05 2014
    Q2 2014 Bio-Rad Laboratories, Inc. Earnings Release - After Market Close Aug 05 2014
    BIO RAD LABORATORIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 28 2014
    Bio-Rad Announces the Appointment of New Board Member Jul 25 2014
    Bio-Rad to Report Second-Quarter 2014 Financial Results Tuesday, August 5, 2014 Jul 07 2014
    BIO RAD LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Jun 26 2014
    Bio-Rad Unveils Vitamin-D Test in International Market Jun 24 2014
    Bio-Rad Launches Vitamin D Kit for Its BioPlex 2200 System Jun 23 2014
    Bio-Rad Launches the First Fully-Automated 5th Generation HIV Test Jun 17 2014
    Levin Capital reports 5.2% passive stake in Bio-Rad May 08 2014
    BIO RAD LABORATORIES INC Files SEC form 10-Q, Quarterly Report May 08 2014
    Bio-Rad Laboratories' (BIO) CEO Norman Schwartz on Q1 2014 Results - Earnings Call Transcript May 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK